This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: The Brigham and Women's Hospital, Inc., Genzyme Corporation. Active years: 2013-2019.
Company Filing History:
4 out of 1,424 
1 out of 823 
Years Active: 2013-2019
Title: Michael Schlossmacher: Innovator in Synucleinopathy Treatment
Introduction
Michael Schlossmacher is a notable inventor based in Ottawa, Canada, recognized for his contributions to the field of medical treatments, particularly in the area of synucleinopathies. With a total of four patents to his name, he has made significant strides in developing innovative solutions for complex medical conditions.
Latest Patents
Among his latest patents, one focuses on the treatment of synucleinopathies. This invention relates generally to treating synucleinopathies in subjects that are not clinically diagnosed with a lysosomal storage disease. It also includes associated methods of making medicaments and screening methods. This innovative approach aims to provide new avenues for treatment and improve patient outcomes.
Career Highlights
Throughout his career, Michael has worked with esteemed organizations such as The Brigham and Women's Hospital, Inc. and Genzyme Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Valerie Cullen and Lamya S Shihabuddin. Their collaborative efforts have further advanced the research and development of treatments for synucleinopathies.
Conclusion
Michael Schlossmacher's work in the treatment of synucleinopathies showcases his dedication to innovation in the medical field. His patents and collaborations reflect a commitment to improving healthcare solutions for patients.